Recombinant C1q And Tumor Necrosis Factor Related Protein 9 (C1QTNF9)

CTRP9; C1QTNF9A; AQL1; Complement C1q and tumor necrosis factor-related protein 9A

  • Product No.RPR877Hu01
  • Organism SpeciesHomo sapiens (Human) Same name, Different species.
  • SourceProkaryotic expression
  • HostE.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationSecreted
  • Predicted Molecular Mass36.2kDa
  • Accurate Molecular Mass38kDa(Analysis of differences refer to the manual)
  • Residues & TagsGln20~Pro333 with N-terminal His Tag
  • Buffer Formulation100mMNaHCO3, 500mMNaCl, pH8.3, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder
  • Purity> 95%
  • Isoelectric Point8.7
  • Applications Positive Control; Immunogen; SDS-PAGE; WB.
    If bio-activity of the protein is needed, please check active protein.
  • DownloadInstruction Manual
  • UOM 10µg50µg 200µg 1mg 5mg
  • FOB US$ 180  US$ 450  US$ 900  US$ 2700  US$ 6750 
    For more details, please contact local distributors!

SEQUENCE

USAGE

Reconstitute in ddH2O to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
Int J Obes (Lond). Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans. Pubmed: 24357853
J Clin Endocrinol Metab.? Association of Serum C1q/TNF-Related Protein-9 Concentration With Arterial Stiffness in Subjects With Type 2 Diabetes Pubmed:25105737
J Clin Endocrinol Metab.  C1q/TNF-Related Protein-9 (CTRP9) Levels Are Associated With Obesity and Decrease Following Weight Loss Surgery Pubmed:26982010
PLoS One. Circulating C1q complement/TNF-related protein (CTRP) 1, CTRP9, CTRP12 and CTRP13 concentrations in Type 2 diabetes mellitus: In vivo regulation by glucose. pubmed:28207876
Journal of Diabetes Research Plasma C1q/TNF-Related Protein-9 Levels Are Associated with Atherosclerosis in Patients withType 2 Diabetes without Renal Dysfunction. pubmed:28070523
diabetes research and clinical practice Circulating CTRP9 levels are increased in patients with newly diagnosed type 2 diabetes and correlated with insulin resistance pubmed:28743061
PLoS One Association of circulating CTRP9 with soluble adhesion molecules and inflammatory markers in patients with type 2 diabetes mellitus and coronary artery … Pubmed:29381773
archives of insect biochemistry and physiology Effect of a single bout of resistance exercise on zinc-α2-glycoprotein Pubmed: 31686532
J Diabetes Investig Association of serum CTRP9 levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus 33417302
Neurol Ther Association Between Serum C1q Tumor Necrosis Factor-Related Protein 9 and the Clinical Characteristics and Prognosis of Ischemic Stroke 34727346
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPR877Hu01 Recombinant C1q And Tumor Necrosis Factor Related Protein 9 (C1QTNF9) Positive Control; Immunogen; SDS-PAGE; WB.
PAR877Hu01 Polyclonal Antibody to C1q And Tumor Necrosis Factor Related Protein 9 (C1QTNF9) WB; IHC; ICC; IP.
MAR877Hu21 Monoclonal Antibody to C1q And Tumor Necrosis Factor Related Protein 9 (C1QTNF9) WB; IHC; ICC; IP.
SER877Hu ELISA Kit for C1q And Tumor Necrosis Factor Related Protein 9 (C1QTNF9) Enzyme-linked immunosorbent assay for Antigen Detection.
LMR877Hu Multiplex Assay Kit for C1q And Tumor Necrosis Factor Related Protein 9 (C1QTNF9) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.